Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorHamis, Sara
dc.contributor.authorPowathil, Gibin
dc.contributor.authorChaplain, Mark A. J.
dc.date.accessioned2019-08-10T23:42:26Z
dc.date.available2019-08-10T23:42:26Z
dc.date.issued2019-02-11
dc.identifier.citationHamis , S , Powathil , G & Chaplain , M A J 2019 , ' Blackboard-to-bedside : a mathematical modeling bottom-up approach towards personalized cancer treatments ' , JCO Clinical Cancer Informatics , vol. 2019 , no. 3 . https://doi.org/10.1200/CCI.18.00068en
dc.identifier.issn2473-4276
dc.identifier.otherPURE: 255932802
dc.identifier.otherPURE UUID: 0766f9fa-9920-408b-959e-0b6ed611916f
dc.identifier.otherScopus: 85061386864
dc.identifier.otherWOS: 000461065200001
dc.identifier.urihttps://hdl.handle.net/10023/18289
dc.description.abstractCancers present with high variability across patients and tumors; thus, cancer care, in terms of disease prevention, detection, and control, can highly benefit from a personalized approach. For a comprehensive personalized oncology practice, this personalization should ideally consider data gathered from various information levels, which range from the macroscale population level down to the microscale tumor level, without omission of the central patient level. Appropriate data mined from each of these levels can significantly contribute in devising personalized treatment plans tailored to the individual patient and tumor. Mathematical models of solid tumors, combined with patient-specific tumor profiles, present a unique opportunity to personalize cancer treatments after detection using a bottom-up approach. Here, we discuss how information harvested from mathematical models and from corresponding in silico experiments can be implemented in preclinical and clinical applications. To conceptually illustrate the power of these models, one such model is presented, and various pertinent tumor and treatment scenarios are demonstrated in silico. The presented model, specifically a multiscale, hybrid cellular automaton, has been fully validated in vitro using multiple cell-line–specific data. We discuss various insights provided by this model and other models like it and their role in designing predictive tools that are both patient, and tumor specific. After refinement and parametrization with appropriate data, such in silico tools have the potential to be used in a clinical setting to aid in treatment protocols and decision making.
dc.format.extent11
dc.language.isoeng
dc.relation.ispartofJCO Clinical Cancer Informaticsen
dc.rights© 2019, American Society of Clinical Oncology. This work has been made available online in accordance with the publisher's policies. This is the final published version of the work, which was originally published at https://doi.org/10.1200/CCI.18.00068en
dc.subjectQA Mathematicsen
dc.subjectRC0254 Neoplasms. Tumors. Oncology (including Cancer)en
dc.subjectT-NDASen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subject.lccQAen
dc.subject.lccRC0254en
dc.titleBlackboard-to-bedside : a mathematical modeling bottom-up approach towards personalized cancer treatmentsen
dc.typeJournal itemen
dc.description.versionPublisher PDFen
dc.contributor.institutionUniversity of St Andrews. School of Mathematics and Statisticsen
dc.contributor.institutionUniversity of St Andrews. Applied Mathematicsen
dc.identifier.doihttps://doi.org/10.1200/CCI.18.00068
dc.description.statusPeer revieweden
dc.date.embargoedUntil2019-08-11


This item appears in the following Collection(s)

Show simple item record